Since discovery of the first antibiotic drug, penicillin, in 1928, a variety of antibiotic and
antimicrobial agents have been developed and used for both human therapy and industrial …

Nanobiotechnology is considered to be one of the fastest emerging fields. It is still a
relatively new and exciting area of research with considerable potential for development …

Leishmaniasis is a widely distributed protozoan vector-born disease affecting almost 350
million people. Initially, chemotherapeutic drugs were employed for leishmania treatment but …

Utility of silver metal in antimicrobial therapy is an accepted practice since ages that faded
with time because of the identification of a few silver resistant strains in the contemporary …

Abstract Leishmaniasis is a Neglected Tropical Diseases caused by protozoan parasites of
the genus Leishmania. It is a major health problem in many tropical and subtropical regions …

The usage of nanotechnology in the fight against parasitic diseases is in the early stages of
development, but it brings hopes that this new field will provide a solution to target the early …

The underline study focuses on the comparative physicochemical and morphological
characteristics, electrochemical analysis, and biological properties of green and chemically …

Cutaneous leishmaniasis (CL) is a global public health issue. Conventional treatments have
substantial costs, side effects, and parasite resistance. Due to easy application and …

Antimicrobial resistance (AMR), one of the most serious worldwide public health concerns,
poses a serious risk to the establishment of pathogenic organisms that are multidrug …

Leishmaniasis is a neglected disease caused by protozoa belonging to the Leishmania
genus. Notably, the search for new, promising and potent anti-Leishmania compounds …